急性胰腺炎患者血清淀粉酶、脂肪酶与C反应蛋白水平的变化及临床意义

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the changes and clinical significance of serum amylase (AMS), lipase (LPS) and C-reactive protein (CRP) levels in patients with acute pancreatitis (AP).Methods A total of 997 cases of AP patients admitted to our hospital from March 2015 to July 2018 were selected as the AP group, among them, 835 cases were mild and 162 cases were severe.Altogether 1000 cases of healthy subjects who underwent physical examination in our hospital during the same period were selected as the healthy group.The serum AMS, LPS and CRP levels of the two groups were detected and compared.Results The levels of serum AMS, LPS and CRP in the AP group were higher than those in the healthy group, and the differences were statistically significant (P＜0.05).The levels of serum AMS, LPS and CRP of mild and severe patients were higher than those of the healthy group, and the differences were statistically significant (P＜0.05).The levels of serum AMS, LPS and CRP of the severe patients were higher than those of the mild patients, and the differences were statistically significant (P＜0.05).Conclusion The levels of AMS, LPS and CRP of patients with AP are higher.AMS, LPS and CRP can be used as reference indexes in the diagnosis of AP and its severity.

Key words： Serum amylase Lipase C-reactive protein Acute pancreatitis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIANG Jian-fu
	XIE Xiao-ting

Cite this article:

LIANG Jian-fu,XIE Xiao-ting. Changes and clinical significances of serum amylase, lipase and C-reactive protein levels in patients with acute pancreatitis[J]. 中国当代医药, 2020, 27(8): 166-168.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I8/166

[1]	Filik L.Impact of pancreatitis on survival for pancreatic cancer[J].Pancreatology，2019，19（2）：397.
[2]	Tomescu D，Popescu MH，David C，et al.Clinical effects of hemoadsorption with CytoSorbRin patients with severe acute pancreatitis：A case series[J].Int J Artif Organs，2019，42（4）：190-193.
[3]	中华医学会消化病学分会胰腺疾病学组，中华胰腺病杂志编辑委员会，中华消化杂志编辑委员会.中国急性胰腺炎诊治指南（2013年，上海）[J].临床肝胆病杂志，2013，29（9）：656-660.
[4]	Huang Y，Xiao J，Cai T，et al.Immature granulocytes：A novel biomarker of acute respiratory distress syndrome in patients with acute pancreatitis[J].J Crit Care，2019，50：303-308.
[5]	张凌志，李凯江.急性胰腺炎86例的临床分析[J].河南外科学杂志，2018，24（5）：34-35.
[6]	周波，戴飞跃，翁国虎.急性胰腺炎的诊疗进展[J].现代中西医结合杂志，2015，24（5）：565-567.
[7]	罗善明，艾霞，林丽立，等.丹参注射液联合杂合式血液净化疗法对重症急性胰腺炎患者血清血小板活化因子、淀粉酶水平的影响[J].临床和实验医学杂志，2019，18（4）：413-417.
[8]	Inoue H，Uemura S，Harada K，et al.Risk factors for acute pancreatitis in patients with accidental hypothermia[J].Am J Emerg Med，2019，37（2）：189-193.
[9]	陈静，吴婷.血清脂肪酶对急性胰腺炎的诊断价值探讨[J].医学理论与实践，2019，32（6）：794-797.
[10]	曹友德，陈玮，李浩.急性胰腺炎患者脂肪酶的检测与临床意义[J].中国现代医学杂志，2001，11（6）：90-91.
[11]	姚丽娜，顾建文，史伟峰.淀粉酶、脂肪酶联检对提高急性胰腺炎诊断的临床价值分析[J].临床医药文献电子杂志，2017，4（97）：19 031-19 032.
[12]	许楠.生化检测指标在急性胰腺炎诊断中的临床价值[J].中国当代医药，2018，25（30）：125-127.
[13]	高之峰，王义秋，邢飞，等.血清C-反应蛋白/白蛋白比值对急性胰腺炎患者预后的预测作用[J].徐州医科大学学报，2018，38（9）：571-574.
[14]	李溪，周迎春.血清淀粉酶、C反应蛋白、白细胞联合检测对急性胰腺炎鉴别的价值研究[J].检验医学与临床，2019，16（02）：161-163，167.
[15]	吴松，李治君，沈钢.血淀粉酶等联合检测在急性胰腺炎诊断及预后评估中的价值[J].热带医学杂志，2018，18（5）：621-624.